Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
DAL Delta Air Lines Inc
D Dominion Energy Inc

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.


Last Trade
-0.08 (-0.22%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Transcatheter Heart Valve Replacement Market to Reach USD 10.34 Billion by 2026; Owing to Increasing Prevalence of Cardiovascular Diseases Among Geriatric Population: Fortune Business Insights(TM)

8:26 am ET April 27, 2020 (Globe Newswire) Print

The global Transcatheter Heart Valve Replacement Market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of death cases caused due to cardiac medical conditions worldwide. THVR is a minimally invasive procedure for replacing a narrowed aortic valve which fails to function properly. Most of the THVR products are currently in their investigational stage. Fortune Business Insights(TM) offers a comprehensive overview of the market in their recent report titled, "Transcatheter Heart Valve Replacement Market Size, Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement(TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026."According to this report, the market value stood at USD 4.04 billion in 2018 and is expected to rise at a CAGR of 12.5% during the forecast period set between 2019 to 2026.

Request a Sample Copy of the Research Report:

What are the Objectives of the Report?

The report offers a 360-degree overview of the market, primarily focusing on parameters such as drivers, restraints, opportunities, and challenges. It also discusses the key industry developments, current transcatheter heart valve replacement (TVHR) market trends, and other interesting insights offered by the market. Additionally, the report discusses the market segmentation in detail based on factors such as type, product, end-user, and geography. The report is available for sale on the company website for more information on the market and its purchase.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:

Market Drivers

Rising geriatric Population and Vulnerability to Cardiac Problems will Drive Market

The increasing geriatric population and their vulnerability to various health issues, especially cardiovascular diseases, is a significant factor in promoting transcatheter heart valve replacement market growth. In addition, the rise in the obese population is also expected to aid in the expansion of the market. Furthermore, the increasing popularity of minimally invasive surgeries and the success rates of use of various transcatheters in treatment are expected to create growth opportunities for the market in the long run.

Regional Segmentation:

Increasing Adoption of Minimally Invasive Surgeries to Help Asia Pacific Market Witness Rapid Growth

North America earned the highest transcatheter heart valve replacement market shares with a revenue of USD 1.62 billion in 2018. This is owing to the increasing prevalence of cardiovascular disorders in the region, coupled with the availability of better healthcare and medical aid for patients. Furthermore, government-supported reimbursement policies for the benefit of citizens living in Canada and the U.S. are also boosting the regional market. On the other side, the market in Europe will rank second on account of the increasing demands for minimally invasive surgeries, coupled with the strategic company collaborations and new product launches by companies in the region. However, the market in Asia Pacific will emerge as the fastest-growing region attributable to the increasing number of geriatric population complaining of heart disorders and the growing demand for minimally invasive surgeries in the region.

Quick Buy - Transcatheter Heart Valve Replacement Market Research Report:

Competitive Landscape:

Edwards Lifesciences Focus on Introducing Novel Products Will Aid in its Expansion

The global transcatheter heart valve replacement market is dominated by Edwards Lifesciences on account of the highest number of sales for their SAPIEN product, coupled with the presence of a diverse portfolio. Additionally, the continuous introduction of new products in the market by the company is also helping this company attract the highest transcatheter heart valve replacement market revenue in the forthcoming years. Abbott earned the second position in the market competition. Besides this, other players are entering into mergers and acquisitions, joint ventures, and investing massive amounts on the research and development of heart valves and gaining a competitive edge in the market.

List of Key Companies Operating in the Transcatheter Heart Valve Replacement Market include:

-- Abbott

-- LivaNova PLC

-- Cryolife Inc.

-- Edwards Lifesciences Corporation

-- Boston Scientific Corporation

-- Medtronic

-- Micro interventional Devices Inc.

-- Others

Significant Industry Developments of the Transcatheter Heart Valve Replacement Market include:

Jan 2020 - Tendyne(TM) Transcatheter Mitral Valve Implantation (TMVI) Systemby Abbott received the CE mark and the approval for use all over Europe. It is also considered safe for patients with transcatheter mitral valve repair or open-heart surgery.

March 2017 - FDA approved Melody, the transcatheter pulmonary valve by Medtronic, for treating patients with congenital heart diseases.

Have Any Query? Ask Our Experts:

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Prevalence of Cardiovascular Disorders - For Key Countries

        -- Prevalence of Cardiovascular Disorders - For Key Countries

        -- Key Industry Trends

        -- Technological Advancement

        -- New Product Launches

        -- Key Industry Developments - Mergers, Acquisitions and Partnerships

        -- Global Transcatheter Heart Valve Replacement Market Analysis, Insights and Forecast, 2015-2026

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Product Type

            -- Transcatheter Aortic Valve Replacement (TAVR)

            -- Transcatheter Aortic Valve Replacement (TAVR)

            -- Transcatheter Mitral Valve Replacement (TMVR)

            -- Transcatheter Pulmonary Valve Replacement (TPVR)

            -- Market Analysis, Insights and Forecast - By End User

              -- Hospitals

              -- Hospitals

              -- Specialty Clinics & Others

              -- Market Analysis, Insights and Forecast - By Region

                -- North America

                -- North America

                -- Europe

                -- Asia Pacific

                -- Latin America

                -- Middle East & Africa

                TOC Continued....!

                Request for Customization:

                Have a Look at Related Reports:

                Cardiovascular Devices Market Size, Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026

                Cardiac Rhythm Management (CRM) Devices Market Size, Share and Global Trend Product By (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Geography Forecast to 2026

                Cardiac Pacemakers Market Size, Share and Global Trend By Product (Single Chamber Pacemakers, Dual Chamber Pacemakers, Cardiac Resynchronization Therapy-Pacemakers (CRT-P)), By End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Geography Forecast till 2026

                Defibrillator Market Size, Share and Global Trend By Type (Implantable Cardioverter Defibrillator (ICD), Transvenous ICD, External Defibrillator) By End User(Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Geography Forecast till 2026

                About Us:

                Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                Contact Us:

                Fortune Business Insights(TM) Pvt. Ltd.

                308, Supreme Headquarters,

                Survey No. 36, Baner,

                Pune-Bangalore Highway,

                Pune - 411045, Maharashtra, India.


                US :+1 424 253 0390

                UK : +44 2071 939123

                APAC : +91 744 740 1245


                Fortune Business Insights(TM)

                LinkedIn | Twitter | Blogs

                Press Release:


Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.